Safety Alerts & Recalls
What does this mean?
This recall for Semprex-D capsules was issued at a warehouse and pharmacy level only. The FDA and the companies involved have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you take Semprex-D and are concerned, you should follow up with your doctor.
UCB Manufacturing, Inc and DSM Pharmaceuticals, Inc Recall Two Lots of Semprex-D Capsules
UCB Manufacturing, Inc and DSM Pharmaceuticals, Inc have issued a recall for two lots of Semprex-D capsules (8 mg acrivastine/60 mg pseudoephedrine hydrochloride). Lot numbers A43528 and A43529 are being recalled because because samples from these lots did not pass the manufacturer's routine tests for impurities and by-products from chemical breakdown over time.
Semprex-D contains the active ingredients acrivastine and pseudoephedrine and is commonly used in the treatment of sneezing, cough, runny or stuffy nose, itchy or watery eyes, hives, skin rash, itching, and other symptoms of allergies and the common cold. This recall alert only applies to the select lots of Semprex-D capsules (8 mg acrivastine/60 mg pseudoephedrine hydrochloride). No other acrivastine and pseudoephedrine products were involved in this recall.
To view the FDA notice about this recall, please visit: more information here